Medical specialists from Korea, Republic of tagged as investigators in clinical trials studying Spinal Muscular Atrophy

Total 4 results

Anna Cho, MD
Seen in:
- Seongnam-si, Seoul National University Bundang Hospital
Trials:
- NCT04174157 (Principal Investigator)
Conditions:
- Spinal Muscular Atrophy (SMA)
Hoonchul Kang, MD
Seen in:
- Seoul, Severance Hospital
Trials:
- NCT04174157 (Principal Investigator)
Conditions:
- Spinal Muscular Atrophy (SMA)
Yunjeong Lee, MD
Seen in:
- Daegu, Kyungpook National University Hospital
Trials:
- NCT04174157 (Principal Investigator)
Conditions:
- Spinal Muscular Atrophy (SMA)
Yunjin Lee, MD
Seen in:
- Yangsan, Pusan National University Yangsan Hospital
Trials:
- NCT04174157 (Principal Investigator)
Conditions:
- Spinal Muscular Atrophy (SMA)

Clinical Trials on Spinal Muscular Atrophy

Marco Capogrosso
Roche-Genentech

Recruiting

Spinal Cord Stimulation in Spinal Muscular Atrophy (SCSinSMA)

Spinal Muscular Atrophy Type 3 | Spinal Muscular Atrophy Type 4

United States
Institut de Myologie, France
Institut Roche

Completed

Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular Atrophy (NatHis-SMA)

Type 2 Spinal Muscular Atrophy | Type 3 Spinal Muscular Atrophy

Belgium, France, Germany
Marco Capogrosso
Roche-Genentech

Not yet recruiting

Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper Limb

Spinal Muscular Atrophy | Spinal Muscular Atrophy Type 3 | SMA | Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy 4

United States
Novartis Gene Therapies

Active, not recruiting

Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi

SMA | Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type I | Spinal Muscular Atrophy Type III

United States, Belgium, France, Japan, United Kingdom, Italy, Taiwan, Australia, Canada
Hoffmann-La Roche

Recruiting

A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular Atrophy (MANATEE)

Spinal Muscular Atrophy (SMA)

Belgium, United States, Croatia, Japan, Netherlands, Spain, Canada, Poland, United Kingdom, Portugal, Italy, Australia
Northwell Health

Completed

Effect of Nusinersen on Adults With Spinal Muscular Atrophy

Adult Spinal Muscular Atrophy

United States
Hugh McMillan
Families of Spinal Muscular Atrophy; Gwendolyn Strong Foundation

Terminated

Effect of Low-Dose Celecoxib on SMN2 in Patients With Spinal Muscular Atrophy (SMA)

Spinal Muscular Atrophy (SMA)

Canada
Hoffmann-La Roche
Association Française contre les Myopathies (AFM), Paris

Completed

Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.

Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type III Non Ambulant

Germany, Italy, France, Belgium, Poland, Netherlands, United Kingdom
Istanbul Medipol University Hospital
Istanbul University

Recruiting

The Effect of Aerobic Exercise Training in Patients With Type III Spinal Muscular Atrophy

Neuromuscular Diseases | Spinal Muscular Atrophy Type 3

Turkey
Washington University School of Medicine

Active, not recruiting

Spinraza in Adult Spinal Muscular Atrophy (SAS)

Spinal Muscular Atrophy | Spinal Muscular Atrophy Type 3 | Spinal Muscular Atrophy Type II

United States, Canada

Medical specialists from Korea, Republic of tagged as investigators in clinical trials studying Spinal Muscular Atrophy

Clinical Trials on Spinal Muscular Atrophy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations